Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138891000087115 | HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 157691000087116 | RabIg HYPERRAB S/D Grif | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 157821000087118 | RIg HYPERRAB S/D Grif | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| 95941000087114 | HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | true | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | est un(e) (attribut) | Product containing precisely rabies human immune globulin 150 unit/1 milliliter conventional release solution for injection (clinical drug) | true | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has supplier | Grifols Canada Limited | true | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has precise active ingredient | Rabies human immune globulin (substance) | true | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has basis of strength substance (attribute) | Rabies human immune globulin (substance) | true | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has concentration strength numerator value (attribute) | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | Has concentration strength numerator unit | Unit | true | Inferred relationship | Some | 1 | |
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | a pour principe actif (attribut) | Immunoglobulin | false | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | est un(e) (attribut) | RabIg rabies immunoglobulin unspecified | false | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | a pour principe actif (attribut) | Antiserum (substance) | false | Inferred relationship | Some | ||
| HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | a pour principe actif (attribut) | Rabies human immune globulin (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR